Angiotech - Redefining Success™
Search
  • About Us
    • Corporate Profile
    • Company History
    • Management Team
    • Intellectual Property
  • Products
    • Product Overview
    • Quill™ device
    • 5FU - CVC
    • Interventional
    • Biopsy
    • Ophthalmic
    • Surgical
    • Angiotech Partner Solutions
    • Private Label
  • Healthcare Professionals
    • About...
  • Investors
    • Investor Overview
    • Corporate Governance
    • Events & Webcasts
    • Quarterly Results
    • Proxy Materials
    • SEC Filings
    • FAQ
    • Request Information
  • News
    • Press Releases
    • Email Alerts
  • Careers
  • Contact Us

 Investor Overview

Print

Home › Investor Overview

This information is intended for investors. Please read our website's Terms of Use.

Welcome to Angiotech's Investor Relations section. Use the navigation menu on the left to find up-to-date corporate financial information. Some other helpful links include:

  • Earnings Reports
  • Events and Webcasts
  • Company Information
  • Press Releases

Important Financial Release Dates

  • Q1 : Thursday, May 26, 2011
  • Q2 : Thursday, Aug 11, 2011
  • Q3 : Tuesday, Nov 15, 2011
  • Q4 and Year End : TBD

Investor Relations Contacts

Investors, security analysts and representatives of portfolio management firms may contact:

Carrie Oughton

  • tel: (604) 221-6933
  • email: ir@angio.com.

Investors

  • Investor Overview
  • Corporate Governance
  • Events & Webcasts
  • Quarterly Results
  • Proxy Materials
  • SEC Filings
  • FAQ
  • Request Information

Quick Links

  • Product Overview
  • Events & Webcasts
  • Latest Quarterly Results
  • Press Releases

Home

  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Careers

About Us

  • Corporate Profile
  • Company History
  • Management Team
  • Intellectual Property

Products

  • Product Overview
  • Quill™ device
  • 5FU - CVC
  • Interventional
  • Biopsy
  • Ophthalmic
  • Surgical
  • Angiotech Partner Solutions
  • Private Label

Investors

  • Investor Overview
  • Corporate Governance
  • Events & Webcasts
  • Quarterly Results
  • Proxy Materials
  • SEC Filings
  • FAQ
  • Request Information

News

  • Press Releases
  • Email Alerts

© Copyright 2011 Angiotech. All Rights Reserved.